California's StemCells, Inc., Flatlines; A Look at the Implications
By David Jensen,
California Stem Cell Report
| 06. 01. 2016
Untitled Document
Highlights
Layoffs, clinical trial closed
Conflicts of interest
Implications for CIRM
Risk and stem cell research
Twenty years ago, StemCells, Inc., was more than riding high. Its stock price (split adjusted) had skyrocketed to $2,160 in January of 1996. Its outlook was ebullient. But times have changed. Today the company's stock plummeted as low as 51 cents after it announced that it was closing its doors.
The company said yesterday that it is possible that its shareholders will wind up with nothing. Its 50 employees will lose their jobs this summer. And its latest clinical trial for spinal cord injury has been cancelled because the results do not merit spending any more money.
The company's sudden shutdown surprised and shocked some, but it also demonstrated the level of risk in stem cell research and offered implications for California's $3 billion stem cell agency, which is pushing aggressively to bring a stem cell therapy to market.
StemCells, Inc., was co-founded by two respected academic stem cell researchers, Irv Weissman of Stanford, and Fred Gage of the Scripps...
Related Articles
By Katie LaGrone, WPTV | 06.28.2024
Image by National Cancer Institute from Unsplash
TAMPA, Fla. — A Tampa jury recently found the now-defunct Lung Institute in Tampa guilty of engaging in “deceptive or unfair practices” while it offered customers “valueless” stem cell therapy to treat incurable...
By Gilma Avalos, NBC | 07.03.2024
Image by Josh Appel from Unsplash
The dream of becoming parents is turning into a nightmare for hundreds of people caught up in a surrogacy money scandal.
Some of the individuals are facing infertility or medical challenges, seeing surrogacy as...
By Michael Hiltzik, LA Times | 07.02.2024
Photo by Claire Anderson on Unsplash
Second only to the Supreme Court’s ruling Monday on when presidents are immune from criminal prosecution, the biggest case of the court’s recently completed session involved the age-old conflict between judges and government regulators...
By Sonia Suter and Naomi Cahn, PET | 07.01.2024
Image by Dusdn5959 from Wikimedia Commons
Since the US Supreme Court's 2022 decision to overturn Roe v Wade (see BioNews 1147), there have been worries about the future of IVF in the USA. Both abortion and IVF involve decisions...